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Abstract
In contrast to most RNA viruses, influenza viruses replicate their genome in the nucleus of infected cells. As a result, newly-
synthesized vRNA genomes, in the form of viral ribonucleoprotein complexes (vRNPs), must be exported to the cytoplasm
for productive infection. To characterize the composition of vRNP export complexes and their interplay with the nucleus of
infected cells, we affinity-purified tagged vRNPs from biochemically fractionated infected nuclei. After treatment of infected
cells with leptomycin B, a potent inhibitor of Crm1-mediated export, we isolated vRNP export complexes which,
unexpectedly, were tethered to the host-cell chromatin with very high affinity. At late time points of infection, the cellular
export receptor Crm1 also accumulated at the same regions of the chromatin as vRNPs, which led to a decrease in the
export of other nuclear Crm1 substrates from the nucleus. Interestingly, chromatin targeting of vRNP export complexes
brought them into association with Rcc1, the Ran guanine exchange factor responsible for generating RanGTP and driving
Crm1-dependent nuclear export. Thus, influenza viruses gain preferential access to newly-generated host cell export
machinery by targeting vRNP export complexes at the sites of Ran regeneration.
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Introduction
Influenza viruses are nearly unique among RNA viruses, in that
they perform all of their viral RNA synthesis in the nucleus of
infected cells. While this exceptional attribute provides some
advantages to the virus, such as access to capped cellular pre-
mRNAs and the host splicing machinery, it also presents the
challenge of importing and exporting the viral genome during
early and late infection, respectively. Like other negative-strand
RNA viruses, the influenza virus genome is encapsidated by the
nucleoprotein NP, and is associated with the trimeric viral
polymerase complex consisting of the PA, PB1, and PB2 proteins.
This complex, known as the viral ribonucleoprotein complex
(vRNP), is the minimal infectious unit that is exported from the
nucleus at late time points of infection.
The nuclear export of influenza A vRNPs has been well-studied,
yet many details remain unclear. First reports implicated both the
viral matrix protein M1 as well as the viral nuclear export protein
NEP as crucial co-factors [1–3]; however, the requirement for
each of these proteins has subsequently been questioned [4,5].
vRNP export was shown to be dependent on the cellular export
receptor Crm1, and accordingly cytoplasmic accumulation of
vRNPs can be blocked by leptomycin B [5,6], a potent inhibitor of
Crm1 [7]. However, both NP and NEP bind Crm1 and can be
exported [2,5,8], and thus it is unclear which protein actually
drives vRNP export. The current ‘‘daisy-chain’’ model of vRNP
nuclear export postulates that M1 binds directly to vRNPs, while
NEP acts as a bridge between M1 and Crm1 to facilitate
translocation [9]. Despite evidence of binary interactions between
each of these components, a fully-formed vRNP export complex
has not been isolated from infected cells.
Crm1-dependent nuclear export is driven by a gradient of
RanGTP:RanGDP between the nucleus and the cytoplasm. Crm1
association with its export cargo occurs cooperatively in a multi-
protein complex containing RanGTP and other factors
[10,11,12]. This Crm1-RanGTP-cargo complex is escorted
through the nuclear pore complex to the cytoplasm [13], where
RanGTP is hydrolyzed and the cargo complex dissociates [14].
After nuclear re-import of RanGDP, further export cycles require
the regeneration of RanGTP, which is facilitated by the Ran
guanine exchange factor Rcc1, a process chromatin-bound during
the exchange process [11]. Complex formation of Ran, Crm1 and
Rcc1 was shown in biochemical experiments to be facilitated by
the chaperone protein RanBP3; however, this has not been
confirmed in living cells [12].
Our goal in this work was to investigate both the composition of
influenza vRNP export complexes and their interplay with the
host cell nucleus by taking advantage of our previously-established
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affinity purification of vRNPs from infected cells [15]. Using a
subnuclear fractionation, we identified putative vRNP export
complexes which, surprisingly, were tightly bound to the nuclear
substructure. Interestingly, targeting of vRNPs to these chromatin-
bound nuclear domains retained Crm1 at these same domains,
and thus allowed the virus to usurp the cellular export machinery.
The mechanism of this usurpation appears to occur via ‘‘snatching’’
of recycled Crm1-RanGTP complexes after their nucleotide
exchange by Rcc1 on chromatin. Thus, influenza virus gains
preferential access to host cell export machinery by locating vRNPs
proximal to the sites of RanGTP regeneration.
Results
vRNPs accumulate on chromatin upon nuclear export
inhibition
To identify the components of a vRNP export complex, we
performed vRNP purifications from infected cells at a late time
point after infection. Based on previous reports that vRNPs within
the nucleus can be either soluble or associated with chromatin [16–
19], we postulated that subnuclear fractionation before purification
might segregate vRNPs by their respective functions and thus better
facilitate purification of homogenous vRNP export complexes. We
therefore separated cells into cytoplasmic (‘‘cyt’’), soluble nucleo-
plasmic (‘‘nuc’’), 150 mM NaCl-extractable chromatin (‘‘ch150’’),
and 500 mM NaCl-extractable chromatin (‘‘ch500’’) fractions
(Fig. 1A). Prior to salt extraction, chromatin was digested with a
nuclease. Successful fractionation was confirmed by Western blot
detection of subcellular marker proteins such as tubulin (cytoplasm),
HMGB1 (cytoplasm and nucleoplasm), Pol II or histone H3
(chromatin) (Fig. 1B). In agreement with previous reports [20,21],
differential salt extraction separated chromatin into fractions
containing higher or lower levels of markers of active cellular
transcription (Pol II, TFIIP, Fig. 1B lanes 5–8), indicative of an
approximate functional distinction between the ch150 and ch500
fractions. Interestingly, we repeatedly observed a depletion of Pol II
in the ch150 fraction of infected cells, which likely represents the
well-described degradation of Pol II during infection. [22,23]
To obtain a high yield of intact vRNPs from infected cells,
we used a recombinant WSN strain encoding a C-terminally
Strep-tagged PB2 (rWSN-PB2-Strep). The recombinant virus was
generated as previously described [15,24], and grew to similar
titers as an untagged recombinant WSN (rWSN, Fig. S1A).
Performing Strep-purification using lysates from rWSN-PB2-
Strep-infected cells yields a specific purification of vRNPs with
high efficiency (Fig. S1B+C). By infecting cells with rWSN-PB2-
Strep followed by fractionation and Strep-purification, we were
able to obtain high yields of vRNPs from all 4 fractions assayed
(Figs. S1D + E). To differentiate between soluble trimeric poly-
merase complexes and fully-formed vRNPs, we assayed by West-
ern blot the amounts of co-purified PA, as a marker for the
trimeric polymerase complex, as well as co-purified NP as a
marker for vRNA/cRNA-containing vRNPs. Silver staining of
purified vRNPs from all fractions confirmed that PA and PB2-
Strep were always purified in equimolar amounts (data not shown),
indicating that PB2 is always integrated into a polymerase complex
in our protocol (monomeric, purified PB2-Strep was not detected,
data not shown). Despite digestion of DNA and RNA using
Benzonase prior to chromatin extraction, the ratio of co-purified
NP was not reduced (Fig. S1F), suggesting that the vRNP structure
remains intact during this fractionation procedure. Thus, Strep-
purification after subnuclear fractionation yielded biochemically
equivalent vRNPs from all fractions examined.
In order to enrich vRNP export complexes in the nucleus, we
performed the fractionation/purification experiments in HeLa cells
with or without the Crm1 inhibitor leptomycin B (LMB), which can
potently inhibit the export of influenza vRNPs [7](Fig. 1C). Analysis
of vRNP accumulation by Western blot showed an expected
decrease of fully-formed vRNPs in the cytoplasm after LMB
treatment (Fig. 1D, lanes 1–2, ‘‘NP’’). Surprisingly, a corresponding
increase in nuclear vRNPs after LMB treatment was only found in
the chromatin fraction extracted with 500 mM NaCl (Fig. 1D lanes
7–8 ‘‘ch500’’). The vRNPs derived from this fraction also contained
M1, a necessary vRNP export co-factor. Small amounts of NEP
were also associated with these complexes, which were enhanced
after LMB treatment. Interestingly, NEP also associated with
nucleoplasm-derived vRNPs; however, these vRNPs contained no
detectable M1 and did not accumulate in the nucleus after LMB
treatment, suggesting a different role of NEP in these complexes (see
Discussion). These experiments were also performed in A549 cells,
yielding similar results (data not shown).
To verify that the complexes enriched in the ch500 fraction
after LMB treatment represent vRNP export complexes and not
vRNP replication intermediates, we analyzed the amounts of
vRNA and cRNA in each fraction using primer extension analysis.
vRNA was slightly depleted in the cytoplasm and enriched in both
the ch150 and ch500 fractions after LMB treatment (Fig. 1E),
while no significant differences in cRNA accumulation were
observed. Thus, vRNA, but not cRNA, accumulates on chromatin
after treatment with LMB. We observed discrepancies between
PA/NP accumulation in Fig. 1D and vRNA accumulation in
Fig. 1E, which is likely due to the need to use DNase I, instead of
Benzonase, as the nuclease in the latter experiment, which leads to
a altered chromatin extraction profile (data not shown). However,
in both conditions vRNPs and their components associated with
chromatin when vRNP export was inhibited.
Since nuclear export is presumed to be a very dynamic process
[25], we were surprised that vRNP export complexes were tightly
associated with host cell chromatin and sought a confirmation of
this finding using a separate method. We postulated that, if vRNP
export complexes are indeed formed on less-soluble chromatin, the
major components of these complexes should colocalize in an
immunofluorescence analysis (IFA) in cells from which soluble
proteins and salt-extractable chromatin has been removed, and
the presence of these proteins should be enriched after LMB
Author Summary
Influenza viruses replicate their single-stranded RNA
genomes in the nucleus of infected cells. Since new virus
particles are formed at the plasma membrane, these
genomes must be exported in the form of a viral
ribonucleoprotein complex (vRNP) from the nucleus to
the cytoplasm at a late point during infection. We have
discovered that this nuclear export process involves an
intermediate step whereby the vRNPs are very tightly
tethered to a specific region of dense chromatin. Although
the tight tethering of a complex which should be very
mobile seems paradoxical, we found that this close
association between vRNPs and host cell chromatin
brought the viral complexes into close proximity with
Rcc1, a protein involved in regenerating the host cell
export machinery. Through this targeting, the virus gains
access to the recycled host cell export proteins before they
are able to find a cellular substrate. Thus, the virus hijacks a
vital host process not by direct competition, but by finding
a location from which to ‘‘snatch’’ the host protein
complexes immediately after generation.
Influenza vRNP Export
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Figure 1. Purification of vRNPs after subcellular fractionation. (A) Schematic diagram of subcellular fractionation as described in Materials
and Methods. (B) 16109 HeLa cells were infected with WSN at an MOI of 3 for 9 h or mock-infected. Cells were fractionated as described in (A), and
equal amounts of protein from each fraction were analyzed by Western blot analysis for NP or cellular marker proteins. (C) Schematic workflow of
Strep purification after LMB treatment. (D) 16109 HeLa cells were infected with rWSN-Strep at an MOI of 3 for 9 h. At 3hpi, cells were treated with
10 nM LMB or 0.2% EtOH vehicle. Fractionation and Strep-purification were performed as described in (C), and lysates and eluates were analyzed by
Western blot for indicated proteins. (E) Cells were infected, treated, and fractionated as in (D), except that 50 U/ml DNase I was used as a nuclease,
and total RNA was extracted from each fraction. RNA was analyzed by primer extension using probes specific for segment 6 v/cRNA and 5S rRNA.
doi:10.1371/journal.ppat.1002187.g001
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treatment. To test this hypothesis, we adapted a previously-
described in situ extraction for influenza virus-infected cells on
coverslips [17]. In a first step, all soluble proteins from the
cytoplasm and nucleus were extracted, leaving chromatin-bound
material intact (‘‘Total chromatin’’, Fig. 2A). This chromatin was
then digested with DNase I, and extracted with 250 mM NaCl to
reveal the less-soluble dense chromatin (which we so named due to
the observation that histones associated with dense packing are not
soluble at this concentration [26]), and its associated proteins
(Fig. 2A, ‘‘Dense chromatin’’). We used this extraction process to
analyze the localizations of PA, NP, and NEP by IFA in infected
cells with or without LMB treatment. In unfractionated cells, NP
was retained in the nucleus upon LMB treatment as expected
(Fig. 2B, ‘‘Whole cells’’), whereas when soluble proteins were
removed to reveal all chromatin-bound proteins, we observed
prominent NP nuclear rings as previously described (Fig. 2B,
‘‘Total chromatin’’, [27,28]). However, we detected no difference
in staining intensity between LMB-treated and untreated cells, and
surprisingly, little colocalization between NP and PA. In contrast,
after extraction to reveal dense chromatin-bound material, a
strong colocalization of NP and PA was seen in a reticular pattern
(Fig. 2B, ‘‘Dense chromatin’’), which also overlapped with the
localization of histone H2B (Fig. S2). This appearance of antigens
previously not detectable was surprising, but is a well-known
phenomenon likely caused by the exposure of epitopes previously
covered by other proteins [29]. As expected, an increase in
staining intensity of both PA and NP was observed after LMB
treatment on the dense chromatin, but not on total chromatin or
whole cells (Fig. 2B).
Staining of fractionated cells for NEP revealed a similar
distribution as PA in unfractionated cells (Fig. 2C, ‘‘Whole cells’’),
but no NEP was detected after soluble proteins were removed
(Fig. 2C, ‘‘Total chromatin’’). When dense chromatin was exposed,
no NEP was detectable in control cells, but a faint staining was
observed in LMB-treated cells, which colocalized with PA (Fig. 2C,
‘‘Dense chromatin’’). Similar PA, NP, and NEP distributions after
fractionation were observed when MDCK or A549 cells were
infected, or when HeLa cells were infected with influenza A strain
SC35M (data not shown). Taken together, these results suggest that
colocalization of vRNP export complex components can only be
visualized when both soluble proteins and soluble chromatin-bound
material is removed from the cell. Furthermore, after LMB
treatment, vRNP protein components are enriched only on this
dense chromatin fraction.
Since LMB targets the general cellular export receptor Crm1,
treatment of infected cells may have unspecific effects on vRNP
distribution in the nucleus. We therefore generated a recombinant
WSN virus (WSN-NEP20/21) containing two previously-described
mutations (Q20L, L21C) [30] in the nuclear export sequence
(NES) of NEP. This mutant virus can synthesize vRNPs at the
same rate as wt (Fig. 3A) but has a delayed vRNP nuclear export
[30] (Fig. 3C, left panels). Fractionation of WSN-NEP20/21-
infected cells at 10 hpi revealed an accumulation of PA, NP and
NEP in the ch500 fraction compared to wt WSN (Fig. 3B).
Correspondingly, colocalization and enrichment of PA, NP and
NEP on the dense chromatin in WSN-NEP20/21-infected cells
were observed by IFA (Fig. 3C and 3D, right panels). Thus,
vRNPs accumulate in this fraction during infection when export is
impaired through a suboptimal NES.
To confirm the importance of high-affinity chromatin associ-
ation for vRNP export, we purified vRNPs from fractionated cells
after treatment with a second chemical inhibitor with a different
mechanism. Among the previously-described inhibitors of influ-
enza vRNP nuclear export, prostaglandin A (PGA) was shown to
block export by inducing overexpression of Hsp70, which in turn
prevents the association of M1 with vRNPs and therefore the
assembly of vRNP export complexes [31]. When we performed
fractionation/purification experiments after PGA treatment, we
observed a decrease in vRNPs in the ch500 fraction (Figs. 4A and
B, lanes 7+8). This decrease corresponded to a lack of detectable
NP or PA on the dense chromatin layer by IFA after PGA
treatment (Fig. 4C, lower panels and data not shown). Despite the
decrease in vRNPs in the ch500 fraction, no decrease in the total
amounts of PA or NP was observed in PGA-treated cells (Fig. S3),
as previously reported. Concomitantly, a large decrease in the
amount of chromatin-bound M1 was detected in PGA-treated
cells both by Western blot (Fig. 4B) and IFA (Fig. 4C). These
results suggest that Hsp70 overexpression prevents the association
of vRNP-M1 complexes with chromatin, thereby leading to a lack
of vRNP export.
Crm1 is relocalized to chromatin-bound sites of vRNP
export complexes
Our data suggested that tight association of influenza vRNPs
with chromatin is a prerequisite for their subsequent export, which
has not been described for exported cellular proteins. To test
whether vRNP chromatin association affects the host cell export
machinery, we analyzed the distribution of Crm1 in the nucleus of
infected cells. Biochemical fractionation of virus-infected cells at 9
hpi revealed an accumulation of Crm1 in the ch500 fraction,
which could be reversed upon LMB treatment (Fig. 5A). Similarly,
IFA showed a pronounced relocalization of Crm1 from the
nuclear periphery to the interior of the nucleus, which was
reversible after LMB or PGA treatment (Fig. 5B). This relocaliza-
tion was also observed in infected A549 and MDCK cells (data not
shown). Although Crm1 co-localized only partially with influenza
NP in whole cells (Fig. 5B, middle panels), there was significant co-
localization of Crm1-HA with NEP (Fig. 5C). This relocalization
of Crm1 upon viral infection correlated with an increase of Crm1
at the sites of NP distribution on the dense chromatin (Fig. 5D),
which was also reversed upon LMB or PGA treatment. Interest-
ingly, in WSN-wt-infected cells, redistribution of Crm1 was only
observed in cells containing cytoplasmic NP, implying that Crm1
relocalization and active vRNP export are tightly linked (Fig. 5E,
upper panels). In contrast, we observed many WSN-NEP20/21-
infected cells displaying Crm1 relocalization without cytoplasmic
NP staining (Fig. 5E, lower panels), suggesting that Crm1
relocalization is not strictly dependent on robust vRNP export.
Thus, Crm1 relocalizes to the sites on dense chromatin where
vRNP export complexes also accumulate.
Export of a non-viral Crm1 substrate is impaired in
influenza virus-infected cells
Based on the ability of influenza vRNPs to sequester at least a
portion of cellular Crm1 on the chromatin, we postulated that the
resulting depletion of free Crm1 might impair the export of
cellular Crm1 substrates. To test this hypothesis, we measured the
export efficiency of a non-viral Crm1 substrate in influenza virus-
infected cells compared to uninfected cells. Due to the targeting of
many cellular Crm1 substrates to the nucleus during influenza
virus infection, we used GFP containing an HIV Rev-derived NES
(GFP-NES) as a marker for Crm1-mediated export. Low-level
GFP expression in HeLa cells led to a predominantly nuclear
localization, similar to previous findings [32] (Fig. 6A). In contrast,
GFP-NES localized almost exclusively in the cytoplasm (Fig. 6B,
left panel), and thus provided a suitable measure of an actively-
exported Crm1 substrate, as has been previously reported [33].
Influenza vRNP Export
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Figure 2. Association of vRNP export complexes with subchromatin structure. (A) The fractionation protocol was adapted to cells grown
on coverslips. Cells were fixed after different fractionation steps to reveal the localization of unextracted proteins. HeLa cells were transfected with
histone H2B-GFP or stained with ToPro3 after fixation to demonstrate extraction efficiency. Whole cells = no extraction, Total chr. = detergent
extraction (all soluble proteins removed), Dense chr. = low-salt-extractable chromatin removed. (B) HeLa cells were grown on coverslips, infected
with WSN at an MOI of 3 for 9 h, and treated with 10 nM LMB or 0.2% EtOH at 3 hpi. Cells were fractionated on the coverslips, fixed after fractionated,
and stained for immunofluorescence using antibodies against PA and NP. Optical sections were obtained by confocal microscopy, and detector
settings remained constant for each protein between all samples. (C) As in (B), except using antibodies against PA and NEP.
doi:10.1371/journal.ppat.1002187.g002
Influenza vRNP Export
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Upon influenza virus infection, retention of GFP-NES in the
nucleus was observed after 10 h of infection (during vRNP export)
but not 4 h (Fig. 6B + C), which was also observed in A549 cells
(data not shown). Interestingly, while the majority of virus-infected
cells contained GFP-NES both in the cytoplasm and the nucleus,
treatment of GFP-NES-transfected cells with LMB led to a
predominantly nuclear accumulation (Fig. 6B+C). These results
suggest that influenza virus infection can impair, but not shut off,
the export of non-viral Crm1 substrates. To test whether this
impairment of cellular export was dependent on chromatin
accumulation of influenza vRNPs, we treated infected cells with
PGA, which blocks chromatin association but not total nuclear
accumulation of vRNPs (Fig. 4A). Although some GFP-NES was
retained in mock-infected cells upon PGA treatment (Fig. 6D), no
difference in nuclear retention was observed between mock-
infected and influenza virus-infected cells. Thus, impairment of
cellular export by influenza virus is not only dependent on
accumulation of nuclear vRNPs, but also on their association with
the ch500 fraction.
As shown in Fig. 5E, infection with the mutant WSN-NEP20/21
could induce Crm1 relocalization to an equivalent extent as wt
WSN, despite reduced vRNP export. In GFP-NES transfected
Figure 3. Accumulation of vRNPs on chromatin during infection with WSN-NEP20/21. (A) HeLa cells were infected with WSN or WSN-NEP20/21
at an MOI of 3 for 7 h. Whole-cell lysates were analyzed by Western blot for accumulation of PA or NP. (B) 16109 HeLa cells were infected with WSN or
WSN-NEP20/21 at an MOI of 3 for 9 h, then fractionated as in Fig. 1B. Fractionated lysates were analyzed by Western blot for PA, NP or NEP accumulation.
(C) HeLa cells on coverslips were infected with WSN or WSN-NEP20/21 at an MOI of 3 for 9 h, then fractionated as described in Fig. 2B and stained for IFA
using antibodies against PA and NP. (D) HeLa cells on coverslips were infected with WSN-NEP20/21 at an MOI of 3 for 9 h, then fractionated as described in
Fig. 2A and stained for IFA using antibodies against PA and NEP.
doi:10.1371/journal.ppat.1002187.g003
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cells, WSN-NEP20/21 inhibited GFP-NES nuclear export equally
as WSN (Fig. 6E). Treatment of these cells with PGA similarly
abrogated any impairment in GFP-NES export (Fig. 6E, right
side). Thus, impairment of cellular Crm1-dependent export by
influenza virus requires vRNP association with chromatin, but not
robust vRNP export.
vRNPs associate with Rcc1 on chromatin
Crm1-dependent nuclear export is driven by association of
Crm1 with the small GTPase Ran in its GTP-bound state.
Exchange of RanGDP for RanGTP is a chromatin-bound process
[11] which is catalyzed by the guanine exchange factor Rcc1,
during which a putative Crm1-Ran-Rcc1 complex can transiently
form [12]. We were therefore interested whether chromatin-
targeting of influenza vRNP export complexes might bring them
into proximity with the sites of RanGTP regeneration. First, we
performed a biochemical fractionation of uninfected or influenza
virus-infected cells to determine the distribution of Rcc1 on
chromatin in our fractionation protocol. Interestingly, the highest
Rcc1 concentration was found in chromatin extracted with
500 mM NaCl (ch500, Fig. 7A), corresponding to the fraction
containing vRNP export complexes. Next, we tested whether Rcc1
and vRNP export complexes can associate on chromatin.
Immunoprecipitation of chromatin-extracted, infected cells using
Rcc1-specific antibodies co-purified NP, PA, and M1, as well as
histone H3 (Fig. 7B). Neither NEP nor Crm1 could be detected in
the immunopurified complexes (data not shown). In summary,
Rcc1 and components of vRNP export complexes can form a
complex, although it is unclear whether this interaction is direct, or
indirect via nucleosomes.
Based on our finding that Crm1 can be retained on chromatin
during influenza virus infection (Fig. 5D), we tested whether
infection causes an increase in formation or stability of Crm1-Ran-
Rcc1 complexes on chromatin. Virus infection indeed led to
accumulation of Ran on dense chromatin (Fig. 7C), partially
colocalizing with NP. We then immunoprecipitated HA-tagged
Crm1 from uninfected or infected cells after chromatin extraction
and measured the amount of bound Ran or Rcc1 by Western blot.
At 9 hpi, more Ran and Rcc1 was co-immunoprecipitated by
Crm1-HA than in uninfected cells (Fig. 7D). Corresponding to our
previous observations, no viral proteins could be detected in the
Crm1-HA-bound complexes (data not shown).
Discussion
Unlike most negative-strand RNA viruses, influenza viruses
require a functional nuclear export system for nucleocytoplasmic
transport of its vRNPs for their incorporation into progeny virions
at late time points of infection. Here, we demonstrate that
exported vRNPs are assembled on a chromatin fraction which can
only be extracted at high salt concentration. Inhibition of Crm1-
mediated nuclear export leads to an accumulation of vRNPs
containing M1 and NEP on this chromatin fraction, while
Figure 4. Depletion of chromatin-bound vRNPs after PGA treatment. (A) Cells were infected and purified as in Fig. 3A, except that treatment
was performed using 20 mg/ml PGA at 3 hpi. Eluted complexes were analyzed by Western blot. (B) Lysates from (A) were analyzed by Western blot.
(C) HeLa cells grown on coverslips were infected as in Fig. 4B, treated at 3 hpi with 20 mg/ml PGA, fractionated at 9 hpi as in Fig. 2A, and analyzed by
immunofluorescence using antibodies specific for NP and M1. Note that the detector sensitivity was increased for the dense chromatin panels to
demonstrate the absence of NP and M1 after PGA treatment.
doi:10.1371/journal.ppat.1002187.g004
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Figure 5. Relocalization of Crm1 to dense chromatin after influenza virus infection. (A) 16109 HeLa cells were infected with WSN at an
MOI of 3 or mock-infected. At 3hpi, cells were treated with LMB or EtOH, and at 9hpi cells were fractionated. Lysates from the ch500 fraction were
analyzed by Western blot for Crm1 or NP. (B) HeLa cells grown on coverslips were infected with WSN at an MOI of 3 or mock-infected. Cells were
treated with EtOH, LMB or PGA at 3hpi, fixed at 9hpi, and analyzed by immunofluorescence using antibodies against NP and Crm1. (C) HeLa cells were
transfected with Crm1-HA, infected with WSN at an MOI of 3 or mock-infected for 9 h, and analyzed by IFA using antibodies against NEP or HA. (D)
Cells were infected and treated as in (B), then fractionated to reveal dense chromatin before fixation and immunofluorescence. (E) HeLa cells were
infected with WSN or WSN-NEP20/21 for 9 h, and analyzed by IFA using antibodies against NP or Crm1.
doi:10.1371/journal.ppat.1002187.g005
Influenza vRNP Export
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sequestration of M1 and vRNPs by Hsp70 overexpression prevents
their association with this chromatin fraction, thus leading to a
lack of vRNP export. Accumulation of vRNPs on the chromatin
immediately prior to their export leads to retention of the cellular
export proteins Crm1 and Ran at these chromatin-bound sites of
vRNP export complex assembly. This relocalization of Crm1 results
in a decrease in the nuclear export of other Crm1 substrates.
Intriguingly, these sites of vRNP export complex assembly are
physically associated with the Ran nucleotide exchange factor Rcc1,
and influenza virus infection leads to an increase in the association
between Rcc1, Ran, and Crm1.
Several lines of evidence confirm that the vRNPs purified from
500 mM NaCl-extractable chromatin are genuine vRNP export
complex precursors. First, these complexes contain both M1 and
NEP (Fig. 1D). Although the amount of co-purified NEP was
relatively low, it is unclear whether a large amount of the protein is
Figure 6. Influenza infection impairs nuclear export of a Crm1-dependent protein. (A) HeLa cells grown on coverslips were transfected
with GFP, mock infected, and fixed. (B) HeLa cells grown on coverslips were transfected with GFP-NES and either infected with WSN at an MOI of 3,
mock-infected, or treated with LMB. At the times indicated, cells were fixed, and GFP was detected by confocal microscopy. (C) Cells from (B) were
scored for the percentage of GFP-expressing cells which displayed either predominantly cytoplasmic (C), approximately equal cytoplasmic and
nuclear (C/N), or predominantly nuclear (N) GFP distribution. Values are the average of three independent assays. (D) HeLa cells grown on coverslips
were transfected with GFP-NES and either infected or mock-infected at an MOI of 3 for 10 h, and treated with PGA at 3hpi. At the times indicated,
cells were fixed, and GFP localization was scored as in (C). (E) HeLa cells transfected with GFP-NES were infected with WSN or WSN-NEP20/21 at an MOI
of 3 for 9 h, and some treated with PGA at 3hpi. GFP localization was scored as in (C).
doi:10.1371/journal.ppat.1002187.g006
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required for export [5]; conversely, vRNPs from the ch500
fraction contained the highest concentration of M1, which is a
major driver of vRNP nuclear export [1,4]. Second, only these
complexes are enriched after vRNP nuclear export is blocked
either through inhibition of cellular export (Fig. 1D) or mutation of
the NES required for vRNP export (WSN-NEP20/21, Fig. 3A + B).
Third, while IFA of unfractionated cells revealed a large
discrepancy between the distributions of PA and NP in the
nucleus (Fig. 2B), extracting all proteins except those bound to
chromatin with high affinity showed a colocalization between PA,
NP, M1, and NEP, all involved in vRNP export (Figs. 2B + C and
data not shown). The exposure of previously-hidden epitopes
through extraction has been previously described [29], and likely
explains the differences in NP distribution observed between
unextracted and chromatin-extracted cells on coverslips. Con-
firming the biochemical fractionation results, the accumulation of
PA, NP, and NEP on dense chromatin also increased after LMB
treatment, while no difference was observed on total chromatin or
in unextracted cells (Fig. 2B + C). Thus, the vRNP export complex
appears to assemble on dense chromatin, from which it trans-
locates to the cytoplasm in a process most likely too transient to
capture using our steady-state methods.
One open question in our data is where in the nucleus vRNP
export complexes are synthesized. Our finding that PGA treatment
reduces the association of vRNPs with chromatin (Fig. 4) suggests
that vRNPs are synthesized elsewhere in the nucleus and
subsequently associate with the ch500 fraction after synthesis in
an M1-dependent manner. Interestingly, previous studies using in
vitro transcription assays demonstrated that some portion of vRNA
can be synthesized on ‘‘nuclear matrix’’-like, high-salt insensitive
chromatin [18,34], suggesting the possibility that both vRNP
synthesis and export complex assembly are chromatin-bound.
Interestingly, we also purified vRNPs containing NEP from the
nucleoplasm (Figs. 1D, 4A). However, these complexes contained
no detectable M1, and were not enriched after LMB treatment.
Recently, several reports have described a role for NEP in viral
RNA replication, including evidence that NEP by itself can
increase cRNA and vRNA synthesis in a vRNP reconstitution
assay [35,36]. We therefore speculate that these NEP-containing
vRNPs are not exported from the nucleus, but may be involved in
the synthesis of full-length viral genomic RNA or cRNA.
Both Crm1 and Ran are very dynamic proteins, which
constantly ‘‘scan’’ the nucleus for potential export substrates via
diffusion through the soluble region of the nucleus [37,38].
Although little is known about the nuclear locations at which
Crm1 associates with its cargo, many Crm1 substrates, such as
nuclear receptors, are very mobile proteins which associate tran-
siently with actively transcribing chromatin [39]. In contrast,
Figure 7. Association of Rcc1 with vRNPs and Crm1. (A) 16109 HeLa cells were infected with WSN at an MOI of 3 or mock-infected for 9 h. Cells
were fractionated, and nuclear lysates were analyzed for distribution of Rcc1. (B) 16109 HeLa cells were infected with WSN at an MOI of 3 for 9 h.
Nuclease-digested lysates were incubated with anti-Rcc1 antibodies or pre-immune serum (IgG) and precipitated with Protein G agarose.
Immunoprecipitates and input lysates were analyzed by Western blot for the indicated proteins. (C) HeLa cells grown on coverslips were infected with
WSN at an MOI of 3 or mock-infected. Whole cells were fixed at 9hpi, and analyzed by IFA using antibodies against NP and Ran. (D) 26108 HeLa cells
were transfected with an expression plasmid encoding HA-tagged Crm1. 16 h post-transfection, cells were infected with WSN at an MOI of 3 or mock-
infected for 9 h. Cells were fractionated, and chromatin lysates were immunoprecipitated using monoclonal HA antibodies. Lysates and precipitates
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RanGTP regeneration by Rcc1 has been shown to be a tightly
chromatin-bound process [38,40]. Our fractionation data suggest
that Rcc1 associates with a dense, less transcriptionally-active
chromatin fraction, raising the possibility that RanGTP regener-
ation and Crm1 cargo recognition occur at biochemically and
spatially distinct domains in uninfected cells. This separation
would provide an unexploited ‘‘niche’’ for influenza vRNPs to
access Crm1-RanGTP complexes before they diffuse to other sites
of the nucleus. While we cannot determine whether there is a
direct contact between Rcc1 and vRNPs (Fig. 7B), both complexes
appear to be located on the same nucleosomes, and the ability of
influenza virus infection to stabilize the Rcc1-Ran-Crm1 complex
(Fig. 7D) suggests that chromatin docking of vRNP export
complexes may directly elicit an alteration of Rcc1. The lack of
co-precipitated Crm1 or NEP with Rcc1-vRNP complexes
(Fig. 7B) is likely due to the very transient nature of both Crm1
and NEP interactions (unpublished observations). Moreover, there
is a possibility that different transient complexes between vRNPs,
Crm1, and Rcc1 are assembled sequentially on nucleosomes,
which could contribute to the asymmetry between Crm1 and Rcc1
immunoprecipitation data.
Based on our findings, we propose that influenza vRNPs gain
preferential access to newly-regenerated host cell export machin-
ery through specific chromatin targeting, which confers a physical
proximity to the sites of Ran nucleotide exchange (see model in
Fig. 8). During late time points of infection, vRNPs associate
transiently with dense chromatin, and assemble with M1 and NEP
at these sites (Fig. 1D, Fig. 2B+C). This targeting is likely mediated
by M1 itself, since M1 can bind to chromatin with high affinity
[19,41], and is sequestered from chromatin after Hsp70 over-
expression (Fig. 4B). These chromatin-bound sites of vRNP export
complex assembly are associated either directly or via nucleosomes
with Rcc1, on which a transient Crm1-Ran-Rcc1 complex is
formed in order to regenerate RanGTP from RanGDP [12]. We
postulate that the proximity of these components allows influenza
vRNPs to ‘‘snatch’’ newly-generated Crm1-RanGTP complexes
before they can diffuse to cellular NES-containing substrates at
distal nuclear sites (Fig. 8).
This sequestering of Crm1/RanGTP on the chromatin is a
likely cause of GFP-NES retention in the nucleus of infected cells
(Fig. 6). Although GFP-NES is not a cellular Crm1 substrate, it is
generally accepted as a marker for Crm1 activity [42], and was
expressed at low levels in our assay. By retaining a portion of
Crm1 on the chromatin, influenza virus infection may reduce the
pool of free, soluble Crm1 available to facilitate the export of other
proteins more distant from Rcc1. Unlike other RNA viruses
[43,44], influenza virus infection impaired but did not completely
block nuclear export, thus keeping intact a cellular system required
for viral propagation. Impairment of cellular export seems to be a
specific consequence of vRNP association with chromatin:
accumulation of vRNPs in the nucleus without chromatin associa-
tion did not affect export (Fig. 6C, PGA), while vRNP association
with chromatin in the absence of vRNP nuclear export led to a
decrease in cellular export (Fig. 6D, WSN-NEP20/21). Based on
these findings, we postulate that influenza vRNPs gain preferential
access to Crm1 in the nucleus, to the detriment of cellular export
substrates.
In summary, we show here that influenza viruses use a unique
chromatin-targeting strategy to facilitate vRNP export. The
chromatin association of vRNPs leads to a retention of Crm1 and
Ran, which in turn impairs the ability of other Crm1 substrates to be
exported. Thus, we postulate that influenza vRNPs gain an
advantage in nuclear export over cellular substrates through chro-
matin association and subsequent Crm1 ‘‘snatching.’’ While other
examples of host-cell hijacking by viruses involve higher binding
affinities or shutting off of cellular processes, influenza viruses
appear to exploit an unused locational niche in gaining preferential
access to the cellular export machinery.
Materials and Methods
Ethics statement
All animal experiments were performed in compliance with the
German guidelines according to 1 8a Animal Welfare Act of 18.
May 2006 (BGBI.I, p. 1206), European Union guidelines 86/609/
EWG of 24.11.1986 and according to the European Agreement of
18.3.1996 for protection of animal trials and other for scientific
purposes used vertebrates of 11.12.1990 (BGBI. II S. 1486) and
NIH/OLAW Animal Welfare Assurance #A5755-010. The
animal welfare committees of the Robert Koch Institute and the
Institute of Biotechnology of Vilnius University approved all
animal experiments.
Antibodies
Hybridomas producing monoclonal antibodies (MAbs) against
PA (A/WSN/33) were generated essentially as described by ([45]).
Eight-week-old female BALB/c mice (obtained from a breeding
colony at the Institute for Innovative Medicine, Vilnius, Lithuania)
were immunized at days 0, 28 and 56 by a subcutaneous injection
of 50 mg of recombinant purified PA [46]. The specificity of MAbs
was tested by an indirect ELISA. Twenty five hybridomas giving
initial ELISA reactivities (OD450) against full-length recombinant
PA OD450 .2.0 were identified and subcloned. After subcloning,
22 stable hybridoma cell lines producing MAbs of IgG isotype
IgG1 subtype were obtained. The MAb produced by clone 1E7,
used in this study, showed high reactive against recombinant full-
length C9 terminally hexahistidine-tagged Flu A PA both by
ELISA and Western blot (data not shown). The MAb 1E7 did not
cross-react using purified C-terminally His-tagged Flu B PA and
lysates of either non-transformed yeast cells.
Influenza-specific anti-NP antibodies have been previously
described [47], while polyclonal anti-NEP antibody was generated
Figure 8. Model of vRNP export. vRNPs (light gray) complexed with
M1 (blue) and NEP (red) associate with dense chromatin in proximity to
Rcc1 (orange). During or immediately after generation of RanGTP
(purple), the proximity of vRNPs to Rcc1 may allow vRNPs access to a
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by immunizing a rabbit with recombinant glutathione-S-transfer-
ase fused to NEP derived from the influenza A/PR/8/34 virus.
All other antibodies were purchased: anti-M1 (ab22396), anti-
histone H3 (ab1791), anti-HMGB1 (ab18256), and anti-Rcc1
(ab54600) from Abcam; anti-Crm1 (sc-5595) from Santa Cruz
Biotechnology; anti-TFIIB from Euromedex; anti-Pol II (8WG16)
from Covance; anti-tubulin from Sigma-Aldrich; and anti-Ran
(610341) from BD Transduction Laboratories. All secondary
antibodies were purchased from Jackson Immunoresearch.
Cell lines and chemicals
HeLa, A549 and MDCK cells were cultured in DMEM
containing penicillin and streptomycin.
Prostaglandin A (PGA) was purchased from Sigma and stored at
a stock concentration of 5 mg/ml in ethanol. Leptomycin B was
purchased from Enzo Biochemicals and stored at a stock
concentration of 5 mg/ml in ethanol.
Virus strains and infections
Recombinant viruses rWSN-PB2-Strep and rWSN (untagged)
were generated as previously described [24]. Viruses were diluted
in phosphate-buffered saline (PBS) containing 0.3% bovine serum
albumin (BSA), and cells were infected for 1 h at 37uC. Virus titers
from supernatants were performed on MDCK cells using standard
plaque assay protocol. WSN-NEP20/21 was generated by site-
directed mutagenesis based on the sequence in ([30]) in the
plasmid pPOLI-NS [48].
Plasmids
Plasmid pCA-GFP-NES was generated from pCA-Flag-GFP
[46] using a reverse primer containing the HIV Rev NES
sequence (LQLPPLERLTLD) preceded by a linker ecoding three
glycine residues and followed by a stop codon and a BglII
restriction site. PCR was performed using this primer and a GFP-
specific forward primer, and the product was digested and ligated
into the digested vector.
Subcellular fractionation
109 HeLa cells were washed and pelleted in PBS. The cell pellet
was resuspended in 10 ml sucrose buffer (10 mM HEPES pH 7.9,
10 mM KCl, 2 mM Mg acetate, 3 mM CaCl2, 340 mM sucrose,
1 mM DTT, 1 mM PMSF), and cells were incubated 10 min. on
ice. NP-40 was then added to a final concentration of 0.5%,
followed by vortexing for 15 sec and centrifugation for 10 min at
4uC at 3,500 g. Supernatant was saved as the cytoplasmic fraction,
and the nuclear pellet was washed once with 5 ml sucrose buffer.
The nuclear pellet was then resuspended in 1.5 ml nucleoplasm
extraction buffer (50 mM HEPES pH 7.9, 150 mM potassium
acetate, 1.5 mM MgCl2, 0.1% NP-40, 1 mM DTT, 1 mM
PMSF), transferred to an all-glass 4 ml Dounce homogenizer with
a tight-fitting pestle, and homogenized with 20 strokes. Homog-
enate was then incubated 20 min at 4uC on a rotating wheel,
followed by centrifugation for 10 min at 4uC at 14,000 rpm in a
microcentrifuge. The supernatant was saved as the nucleoplasmic
fraction, and the pellet was resuspended in 1.5 ml nuclease
incubation buffer (50 mM HEPES pH 7.9, 10 mM NaCl,
1.5 mM MgCl2, 1 mM DTT, 1 mM PMSF) containing 100 U/
ml Benzonase nuclease (Novagen). Chromatin was digested for 109
at 37uC, followed by addition of NaCl to 150 mM and further
incubation 20 min on ice. Digested lysate was then centrifuged
10 min at 4uC at 14,000 rpm, and supernatant was saved as the
low-salt chromatin fraction. The pellet was resuspended in 1.5 ml
chromatin extraction buffer (50 mM HEPES pH 7.9, 500 mM
NaCl, 1.5 mM MgCl2, 0.1% Triton X-100, 1 mM DTT, 1 mM
PMSF) and incubated 20 min on ice, followed by centrifugation as
above. The supernatant was saved as the high-salt chromatin
fraction.
Strep-tag purification
100 ml Strep-Tactin Sepharose (IBA) was washed with 30
volumes strep wash buffer (20 mM HEPES pH 7.9, 150 mM
NaCl, 1 mM EDTA) and added to fractionated lysates. Lysates
were incubated with beads for 1 h at 4uC on a rotating wheel.
Beads were collected by centrifugation, washed three times with
strep wash buffer (containing 500 mM NaCl for high-salt
chromatin samples), and eluted with 100 ml strep wash buffer
containing 2.5 mM desthiobiotin (IBA). Eluates were diluted 1:1
with 2x Lämmli buffer for further analysis.
Primer extension
For primer extension, cells were first fractionated as above,
except that Benzonase nuclease was replaced with 20 U/ml
RNase-free DNase I (Fermentas). RNA was then extracted from
each fraction using a Nucleospin RNA II Kit (Macherey-Nagel).
Primer extension was performed using WSN NA-specific primers
as previously described [35].
In situ fractionation and immunofluorescence
HeLa cells grown on coverslips were washed once with cold PBS,
then incubated with 250 ml/well CSK (50 mM PIPES pH 6.8,
100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM PMSF)
containing 0.5% Triton X-100 for 3 min. on ice, followed by a brief
wash with CSK. Cells were then incubated with 250 ml DB (50 mM
PIPES pH 6.8, 50 mM NaCl, 300 mM sucrose, 3 mM MgCl2,
1 mM CaCl2, 1 mM PMSF) containing 20 U/ml RNase-free
DNase I (Fermentas) for 10 min. at 37uC. This buffer was removed,
and cells were incubated in DB containing 250 mM NaCl for
3 min. on ice. Experiments were performed in triplicate, and one
coverslip each was fixed before the extraction, after detergent
extraction, and after chromatin extraction. Cells were fixed 109 with
3% paraformaldehyde, followed by standard immunofluorescence.
DNA was stained using ToPro3 (Invitrogen). For GFP-NES
experiments, HeLa cells were on coverslips in 24-well plates were
transfected with 200 ng/well pCA-GFP-NES. After infection,
coverslips were mounted on slides directly after fixation. Optical
sections were obtained using a Leica TCS confocal microscope.
Immunoprecipitations
HeLa cells were transfected with a plasmid encoding HA-tagged
Crm1 ([49], kindly provided by R. Kehlenbach, Göttingen,
Germany) using Nanofectin (PAA). 24 h after transfection, cells
were infected for 9 h. Fractionation was then performed as above,
except that high-salt chromatin extraction was performed using
300 mM NaCl instead of 500 mM to prevent disruption of Crm1
complexes. High salt chromatin lysates were incubated with anti-
HA agarose (Sigma-Aldrich) for 1 h at 4uC on a rotating wheel,
then washed three times with strep wash buffer containing
300 mM NaCl. Bound complexes were eluted using Lämmli
buffer and analyzed by Western blot.
For anti-Rcc1 immunoprecipitation, cells were infected 9 h,
then lysed with lysis buffer (50 mM Tris pH 7.5, 250 mM NaCl,
2 mM MgCl2, 0.5% NP-40, 1 mM PMSF, 1 mM DTT)
containing 100 U Benzonase per ml 20 min. on ice. Lysates were
incubated with anti-Rcc1 (Santa Cruz) and precipitated using
Protein G agarose (Pierce). Beads were washed 3 times with lysis
buffer without NP-40 and eluted with Lämmli buffer.
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Supporting Information
Figure S1 Strep-purification of vRNPS. (A) A549 cells were
infected with rWSN or rWSN-PB2-Strep at an MOI of 0.001, and
infectious supernatant titer was determined by plaque assay at
times shown. Error bars represent standard deviation from 3
independent experiments. Infectious titers were not measurable
from HeLa cells, but equal infection kinetics in these cells was
confirmed using immunofluorescence and Western Blot analyses
(not shown). (B) HeLa cells were infected with rWSN or rWSN-
PB2-Strep at an MOI of 3. At 6 hpi, cells were lysed and Strep
purification was performed as described in Materials and
Methods. Lysates and eluates were analyzed by Western blot for
indicated proteins. Equal amounts of lysate from before Strep
purification (left lanes, ‘‘Lysate’’) and after purification (middle
lanes, ‘‘Unbound’’) were loaded. (C) Eluates from (B) were
visualized by silver staining. Upper bands marked by asterisk
were confirmed as RNA by RNase digestion (not shown). (D)
16109 HeLa cells were infected with rWSN or rWSN-PB2-Strep
at an MOI of 3 for 9 h before subcellular fractionation. Equal
amounts of protein from the rWSN-PB2-Strep-infected samples
were analyzed by Western blot for distribution of PA or NP. (E)
Eluates from Strep purification using the lysates from (D) were
analyzed by SDS-PAGE and staining with silver. (F) Eluates from
(E) were analyzed by Western blot for PA or NP amounts, which
were quantified by densitometry, and the ratio of NP:PA in each
fraction was calculated.
(TIF)
Figure S2 Colocalization of NP and histone H2B. HeLa
cells on coverslips were transfected with a plasmid expressing
H2B-GFP, and 16 h later infected with WSN at an MOI of 3 for
9 h. Whole cells (upper panels) or fractionated cells (lower panels,
dense chromatin) were analyzed by IFA for NP and H2B
localization.
(TIF)
Figure S3 Protein accumulation after LMB or PGA
treatment. HeLa cells were infected with WSN at an MOI of
3 for 7 h, and treated with EtOH, LMB, or PGA at 3hpi. Whole-
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